Back to Search Start Over

NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease

Authors :
Eilise M. Ryan
Pranvera Sadiku
Patricia Coelho
Emily R. Watts
Ailiang Zhang
Andrew J. M. Howden
Manuel A. Sanchez-Garcia
Martin Bewley
Joby Cole
Brian J. McHugh
Wesley Vermaelen
Bart Ghesquiere
Peter Carmeliet
Giovanny Rodriguez Blanco
Alex Von Kriegsheim
Yolanda Sanchez
William Rumsey
James F. Callahan
George Cooper
Nicholas Parkinson
Kenneth Baillie
Doreen A. Cantrell
John McCafferty
Gourab Choudhury
Dave Singh
David H. Dockrell
Moira K. B. Whyte
Sarah R. Walmsley
Source :
American Journal of Respiratory and Critical Care Medicine. 207:998-1011
Publication Year :
2023
Publisher :
American Thoracic Society, 2023.

Abstract

Rationale: Chronic obstructive pulmonary disease (COPD) is a disease characterized by persistent airway inflammation and disordered macrophage function. The extent to which alterations in macrophage bioenergetics contribute to impaired antioxidant responses and disease pathogenesis has yet to be fully delineated. Objectives: Through the study of COPD alveolar macrophages (AMs) and peripheral monocyte-derived macrophages (MDMs), we sought to establish if intrinsic defects in core metabolic processes drive macrophage dysfunction and redox imbalance. Methods: AMs and MDMs from donors with COPD and healthy donors underwent functional, metabolic, and transcriptional profiling. Measurements and Main Results: We observed that AMs and MDMs from donors with COPD display a critical depletion in glycolytic- and mitochondrial respiration-derived energy reserves and an overreliance on glycolysis as a source for ATP, resulting in reduced energy status. Defects in oxidative metabolism extend to an impaired redox balance associated with defective expression of the NADPH-generating enzyme, ME1 (malic enzyme 1), a known target of the antioxidant transcription factor NRF2 (nuclear factor erythroid 2-related factor 2). Consequently, selective activation of NRF2 resets the COPD transcriptome, resulting in increased generation of TCA cycle intermediaries, improved energetic status, favorable redox balance, and recovery of macrophage function. Conclusions: In COPD, an inherent loss of metabolic plasticity leads to metabolic exhaustion and reduced redox capacity, which can be rescued by activation of the NRF2 pathway. Targeting these defects, via NRF2 augmentation, may therefore present an attractive therapeutic strategy for the treatment of the aberrant airway inflammation described in COPD. ispartof: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE vol:207 issue:8 pages:998-1011 ispartof: location:United States status: published

Details

ISSN :
15354970 and 1073449X
Volume :
207
Database :
OpenAIRE
Journal :
American Journal of Respiratory and Critical Care Medicine
Accession number :
edsair.doi.dedup.....40854efbfdaf539694ed945e6a78bdf6
Full Text :
https://doi.org/10.1164/rccm.202203-0482oc